Form 4: Co-Diagnostics, Inc. (CODX), Egan Dwight H, transaction 01/15/2021

Summary

A Form 4 filed with the Securities and Exchange Commission by Dwight H. Egan, director and Chief Executive Officer of Co-Diagnostics, Inc. (CODX), for transactions on 01/15/2021. It reports the exercise of 50,000 non-qualified stock options at $2.63 per share, the withholding of 11,954 shares by the issuer to fund the cashless exercise, and the sale of 38,046 shares, leaving 0 shares of common stock owned directly. The explanation states that the option for 150,000 shares was granted on September 21, 2018 under the 2015 Long-Term Incentive Plan, with 50,000 shares vesting in each of three installments. The form is signed /s/ Dwight H. Egan and dated 01/20/2021.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * Egan Dwight H (Last) (First) (Middle) 2401 S. FOOTHILL DRIVE SUITE D (Street) SALT LAKE CITY UT 84109 (City) (State) (Zip) | Egan Dwight H | (Last) | (First) | (Middle) | 2401 S. FOOTHILL DRIVE SUITE D | SALT LAKE CITY | UT | 84109 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol Co-Diagnostics, Inc. [ CODX ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner X Officer (give title below) Other (specify below) Chief Executive Officer | X | Director | 10% Owner | X | Officer (give title below) | Other (specify below) | Chief Executive Officer
3. Date of Earliest Transaction
 (Month/Day/Year) 01/15/2021
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock | 01/15/2021 | M | 50,000 | A | $ 2.63 | 50,000 | D
Common Stock | 01/15/2021 | F | 11,954 (1) | D | $ 2.63 | 38,046 | D
Common Stock | 01/15/2021 | S | 38,046 (2) | D | $ 11 | 0 | D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Non-Qualified Stock Option (right to buy) | $ 2.63 | 01/15/2021 | M | 50,000 | (1) | 09/21/2028 | Common Stock | 100,000 | $ 0.00 | 50,000 | D
Explanation of Responses:
1. On September 21, 2018, the Issuer granted the Reporting Person a Non-Qualified Stock Option exercisable for 150,000 shares of common stock of the Issuer at $2.63 per share. The option was granted pursuant to the Issuer's 2015 Long-Term Incentive Plan and vested in three equal installments, with one-third (50,000 shares) vesting on the issue date and the first and second anniversary of the issue date.
2. Reflects 11,954 shares withheld by the Issuer at the market price of $11.00 per share less the exercise price of $2.63 per share to fund the cashless exercise of 50,000 options owned by the Reporting Person.
/s/ Dwight H. Egan | 01/20/2021
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File

SEC_CODX_4_filed2021-01-20_0001493152-21-001459.xml

Size

17,942 bytes

SHA-256

e3b989add86e42ccbf41aed2960d9ed29b410f2514e26002fb9d549116747b08

Our copy

SEC_CODX_4_filed2021-01-20_0001493152-21-001459.xml

Original

www.sec.gov